Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition

Min A. Seol, Jin Hee Kim, Keunhee Oh, Gwanghun Kim, Myung Won Seo, Young Kyoung Shin, Ji Hyun Sim, Hyun Mu Shin, Bo Yeon Seo, Dong Sup Lee, Ja Lok Ku, Ilkyu Han, Insoo Kang, Serkin Park, Hang Rae Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Precise mechanisms underlying interleukin-7 (IL-7)-mediated tumor invasion remain unclear. Thus, we investigated the role of IL-7 in tumor invasiveness using metastatic prostate cancer PC-3 cell line derivatives, and assessed the potential of IL-7 as a clinical target using a Janus kinase (JAK) inhibitor and an IL-7-blocking antibody. We found that IL-7 stimulated wound-healing migration and invasion of PC-3 cells, increased phosphorylation of signal transducer and activator of transcription 5, Akt, and extracellular signal-regulated kinase. On the other hand, a JAK inhibitor and an IL-7-blocking antibody decreased the invasiveness of PC-3 cells. IL-7 increased tumor sphere formation and expression of epithelial–mesenchymal transition (EMT) markers. Importantly, lentiviral delivery of IL-7Rα to PC-3 cells significantly increased bone metastasis in an experimental murine metastasis model compared to controls. The gene expression profile of human prostate cancer cells from The Cancer Genome Atlas revealed that EMT pathways are strongly associated with prostate cancers that highly express both IL-7 and IL-7Rα. Collectively, these data suggest that IL-7 and/or IL-7Rα are promising targets of inhibiting tumor metastasis.

Original languageEnglish
Article number6917
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - 2019 Dec 1

Fingerprint

Interleukin-7
Prostatic Neoplasms
Janus Kinases
Blocking Antibodies
Neoplasms
Neoplasm Metastasis
STAT5 Transcription Factor
Atlases
Extracellular Signal-Regulated MAP Kinases
Transcriptome
Wound Healing
Phosphorylation
Genome
Bone and Bones
Cell Line

ASJC Scopus subject areas

  • General

Cite this

Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition. / Seol, Min A.; Kim, Jin Hee; Oh, Keunhee; Kim, Gwanghun; Seo, Myung Won; Shin, Young Kyoung; Sim, Ji Hyun; Shin, Hyun Mu; Seo, Bo Yeon; Lee, Dong Sup; Ku, Ja Lok; Han, Ilkyu; Kang, Insoo; Park, Serkin; Kim, Hang Rae.

In: Scientific Reports, Vol. 9, No. 1, 6917, 01.12.2019.

Research output: Contribution to journalArticle

Seol, MA, Kim, JH, Oh, K, Kim, G, Seo, MW, Shin, YK, Sim, JH, Shin, HM, Seo, BY, Lee, DS, Ku, JL, Han, I, Kang, I, Park, S & Kim, HR 2019, 'Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition', Scientific Reports, vol. 9, no. 1, 6917. https://doi.org/10.1038/s41598-019-43294-4
Seol, Min A. ; Kim, Jin Hee ; Oh, Keunhee ; Kim, Gwanghun ; Seo, Myung Won ; Shin, Young Kyoung ; Sim, Ji Hyun ; Shin, Hyun Mu ; Seo, Bo Yeon ; Lee, Dong Sup ; Ku, Ja Lok ; Han, Ilkyu ; Kang, Insoo ; Park, Serkin ; Kim, Hang Rae. / Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition. In: Scientific Reports. 2019 ; Vol. 9, No. 1.
@article{610f4a5df6594396ba3288a81307d91f,
title = "Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition",
abstract = "Precise mechanisms underlying interleukin-7 (IL-7)-mediated tumor invasion remain unclear. Thus, we investigated the role of IL-7 in tumor invasiveness using metastatic prostate cancer PC-3 cell line derivatives, and assessed the potential of IL-7 as a clinical target using a Janus kinase (JAK) inhibitor and an IL-7-blocking antibody. We found that IL-7 stimulated wound-healing migration and invasion of PC-3 cells, increased phosphorylation of signal transducer and activator of transcription 5, Akt, and extracellular signal-regulated kinase. On the other hand, a JAK inhibitor and an IL-7-blocking antibody decreased the invasiveness of PC-3 cells. IL-7 increased tumor sphere formation and expression of epithelial–mesenchymal transition (EMT) markers. Importantly, lentiviral delivery of IL-7Rα to PC-3 cells significantly increased bone metastasis in an experimental murine metastasis model compared to controls. The gene expression profile of human prostate cancer cells from The Cancer Genome Atlas revealed that EMT pathways are strongly associated with prostate cancers that highly express both IL-7 and IL-7Rα. Collectively, these data suggest that IL-7 and/or IL-7Rα are promising targets of inhibiting tumor metastasis.",
author = "Seol, {Min A.} and Kim, {Jin Hee} and Keunhee Oh and Gwanghun Kim and Seo, {Myung Won} and Shin, {Young Kyoung} and Sim, {Ji Hyun} and Shin, {Hyun Mu} and Seo, {Bo Yeon} and Lee, {Dong Sup} and Ku, {Ja Lok} and Ilkyu Han and Insoo Kang and Serkin Park and Kim, {Hang Rae}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-43294-4",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition

AU - Seol, Min A.

AU - Kim, Jin Hee

AU - Oh, Keunhee

AU - Kim, Gwanghun

AU - Seo, Myung Won

AU - Shin, Young Kyoung

AU - Sim, Ji Hyun

AU - Shin, Hyun Mu

AU - Seo, Bo Yeon

AU - Lee, Dong Sup

AU - Ku, Ja Lok

AU - Han, Ilkyu

AU - Kang, Insoo

AU - Park, Serkin

AU - Kim, Hang Rae

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Precise mechanisms underlying interleukin-7 (IL-7)-mediated tumor invasion remain unclear. Thus, we investigated the role of IL-7 in tumor invasiveness using metastatic prostate cancer PC-3 cell line derivatives, and assessed the potential of IL-7 as a clinical target using a Janus kinase (JAK) inhibitor and an IL-7-blocking antibody. We found that IL-7 stimulated wound-healing migration and invasion of PC-3 cells, increased phosphorylation of signal transducer and activator of transcription 5, Akt, and extracellular signal-regulated kinase. On the other hand, a JAK inhibitor and an IL-7-blocking antibody decreased the invasiveness of PC-3 cells. IL-7 increased tumor sphere formation and expression of epithelial–mesenchymal transition (EMT) markers. Importantly, lentiviral delivery of IL-7Rα to PC-3 cells significantly increased bone metastasis in an experimental murine metastasis model compared to controls. The gene expression profile of human prostate cancer cells from The Cancer Genome Atlas revealed that EMT pathways are strongly associated with prostate cancers that highly express both IL-7 and IL-7Rα. Collectively, these data suggest that IL-7 and/or IL-7Rα are promising targets of inhibiting tumor metastasis.

AB - Precise mechanisms underlying interleukin-7 (IL-7)-mediated tumor invasion remain unclear. Thus, we investigated the role of IL-7 in tumor invasiveness using metastatic prostate cancer PC-3 cell line derivatives, and assessed the potential of IL-7 as a clinical target using a Janus kinase (JAK) inhibitor and an IL-7-blocking antibody. We found that IL-7 stimulated wound-healing migration and invasion of PC-3 cells, increased phosphorylation of signal transducer and activator of transcription 5, Akt, and extracellular signal-regulated kinase. On the other hand, a JAK inhibitor and an IL-7-blocking antibody decreased the invasiveness of PC-3 cells. IL-7 increased tumor sphere formation and expression of epithelial–mesenchymal transition (EMT) markers. Importantly, lentiviral delivery of IL-7Rα to PC-3 cells significantly increased bone metastasis in an experimental murine metastasis model compared to controls. The gene expression profile of human prostate cancer cells from The Cancer Genome Atlas revealed that EMT pathways are strongly associated with prostate cancers that highly express both IL-7 and IL-7Rα. Collectively, these data suggest that IL-7 and/or IL-7Rα are promising targets of inhibiting tumor metastasis.

UR - http://www.scopus.com/inward/record.url?scp=85065301298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065301298&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-43294-4

DO - 10.1038/s41598-019-43294-4

M3 - Article

C2 - 31061414

AN - SCOPUS:85065301298

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6917

ER -